
1. annu rev immunol. 2019 apr 26;37:225-246. doi:
10.1146/annurev-immunol-042617-053301. epub 2018 dec 19.

the antibody response plasmodium falciparum: cues vaccine design the
discovery receptor-based antibodies.

tan j(1)(2)(3), piccoli l(1), lanzavecchia a(1)(4).

author information: 
(1)institute research biomedicine, universit√† della svizzera italiana,
6500 bellinzona, switzerland; email: lanzavecchia@irb.usi.ch.
(2)radcliffe department medicine, university oxford, oxford ox3 9du, united
kingdom.
(3)current affiliation: national institute allergy infectious diseases,
rockville, maryland 20852, usa.
(4)vir biotechnology, san francisco, california 94158, usa.

plasmodium falciparum remains serious public health problem continuous
challenge immune system due complexity diversity the
pathogen. recent advances several laboratories characterization of
the antibody response parasite led identification critical 
targets protection revealed new mechanism diversification based on
the insertion host receptors immunoglobulin genes, leading the
production receptor-based antibodies. advances opened new
possibilities vaccine design passive antibody therapies provide
sterilizing immunity control blood-stage parasites.

doi: 10.1146/annurev-immunol-042617-053301 
pmid: 30566366  [indexed medline]

